More recently, down-regulation of TGFBI expression has been reported to be involved in the development of human tumors, including lung, breast, ovarian, prostate, embryonic rhabdomyosarcoma, insulinoma, and mesenchymal tumors [14,16,29-33]. The gene discussed is TGFBI; the disease is mesenchymal cell neoplasm.